Disease Focused

These include focused libraries of small-molecule compounds with potential biological activity towards certain diseases (such as Anti-Cancer Compound Library, Anti-Diabetic Compound Library, Anti-Cardiovascular Disease Compound Library, etc.).

Cat No.	product name
L1700	Anti-Viral Compound Library	A unique collection of 1040 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening;	1040 compounds
L4500	Anti-Fungal Compound Library	A unique collection of 253 antifungal compounds effective for drug repurposing screening, combination screening and biological investigation.	253 compounds
L2150	Anti-Cancer Drug Library	A unique collection of 2900 anticancer drugs for high throughput screening (HTS) and high content screening (HCS);	2900 compounds
L2140	Cancer Cell Differentiation Compound Library	A unique collection of 413 cancer cell differentiation inducing compounds for high throughput and high content screening;	413 compounds
L2130	Anti-Cancer Metabolism Compound Library	A unique collection of 1280 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS);	1280 compounds
L2191	Anti-Breast Cancer Compound Library	A unique collection of 1965 compounds with anti-breast cancer therapeutic activity or targeting breast cancer’s major signaling pathways, can be used for anti-breast cancer drug discovery and mechanism study；	1965 compounds
L2192	Anti-Pancreatic Cancer Compound Library	A unique collection of 2267 pancreatic cancer related compounds can be used in HTS and HCS;	2267 compounds
L9860	Antidepressant Compound Library	1181 compounds associated with depression that can be used for high-throughput and high-content screening	1181 compounds
L1900	Anti-Diabetic Compound Library	A unique collection of 690 diabetes related compounds;	690 compounds
L2120	Anti-Cancer Clinical Compound Library	A unique collection of 2359 anti-cancer compounds for high throughput screening (HTS) and high content screening (HCS);	2359 compounds
L2151	Chemotherapy Drug Library	51 Chemotherapeutic drugs that can be used for high-throughput and high-content screening.	51 compounds
L1710	Anti-COVID-19 Compound Library	A unique collection of 1160 compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents；	1160 compounds
L7110	Anti-Hypertension Compound Library	719 hypertension-related small molecules for high-throughput and high-content screening.	719 compounds
L2110	Anti-Cancer Approved Drug Library	A unique collection of 1806 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS);	1806 compounds
L2180	Anti-Cancer Compound Library Plus	Well-chosen 1468 anti-tumor compounds with unique structures;	1468 compounds
L7100	Anti-Obesity Compound Library	A unique collection of 2286 anti-obesity compounds for high throughput and high content screening;	2286 compounds
L2195	Anti-Prostate Cancer Compound Library	2096 compounds associated with prostate cancer that can be used for high-throughput and high-content screening.	2096 compounds
L1800	Anti-Infection Compound Library	A unique collection of 2977 anti-infective compounds including anti-bacterial, anti-fungi, anti-Human Cytomegalovirus (HCMV), anti-HIV, anti-SARS, anti-influenza, etc;	2977 compounds
L2160	Anti-Cancer Active Compound Library	A unique collection of 2439 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);	2439 compounds
L2190	Anti-Lung Cancer Compound Library	A unique collection of 1735 compounds with anti-lung cancer therapeutic activity or targeting lung cancer’s major signaling pathways, can be used for anti-lung cancer drug discovery and mechanism study；	1735 compounds
L4510	Anti-Parasitic Compound Library	336 well-chosen unique anti-parasitic small molecules;	336 compounds
L4520	Anti-Bacterial Compound Library	A unique collection of 921 antibacterial bioactive compounds, a powerful tool for antibacterial drug development;	921 compounds
L8200	Anti-Aging Compound Library	A unique collection of 3324 anti-aging compounds for high throughput screening (HTS) and high content screening (HCS);	3324 compounds
L2170	Immuno-Oncology Compound Library	A unique collection of 454 compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening；	454 compounds
L9830	Anti-Parkinson's Disease Compound Library	A unique collection of 908 compounds with anti-PD activities or acting on main drug targets of PD can be used for HTS and HCS.	908 compounds
L5200	Anti-Metabolism Disease Compound Library	A unique collection of 1558 metabolism diseases related compounds for high throughput screening (HTS) and high content screening (HCS);	1558 compounds
L9840	Anti-Alzheimer's Disease Compound Library	A unique collection of 1040 compounds with anti-AD activities or acting on main drug targets of AD can be used for HTS and HCS.	1040 compounds
L2193	Anti-Liver Cancer Compound Library	1816 species of compounds related to liver cancer that can be used in anti-liver cancer drug development and pharmacological studies.	1816 compounds
L4710	Nonsteroidal Anti-Inflammatory Compound Library	530 non-steroidal anti-inflammatory compounds for high-throughput and high-content screening.	530 compounds
L2152	Targeted Therapy Drug Library	121 tumor-targeted drugs that can be used for high-throughput and high-content screening.	121 compounds
L2196	Anti-Ovarian Cancer Compound Library		1888 compounds
L4700	Immunology/Inflammation Compound Library	A unique collection of 3483 anti-inflammation compounds effective for high throughput screening and high content screening.	3483 compounds
L2100	Anti-Cancer Compound Library	A unique collection of 6854 compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);	6854 compounds
L5400	Anti-Cardiovascular Disease Compound Library	A unique collection of 1428 cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS);	1428 compounds
L4660	Anti-Nervous System Disease Library	Well-chosen 1246 compounds with unique structures targeting nervous system;	1246 compounds
L2620	Anti-Neurodegenerative Disease Compound Library	A unique collection of 1622 compounds related to neurodegenerative diseases can be used for HTS or HCS；	1622 compounds
L2194	Anti-Colorectal Cancer Compound Library	1565 compounds associated with colorectal cancer that can be used for high-throughput and high-content screening.	1565 compounds
L8400	Hematonosis Compound Library	A unique collection of 524 compounds related to hematologic diseases for high throughput screening (HTS) and high content screening (HCS);	524 compounds
L9810	Anti-Fibrosis Compound Library	A unique collection of 1180 potential anti-fibrosis compounds, can be used in HTS and HCS;	1180 compounds